<p>Distribution of Initial Treatment Modalities by diagnosis of Age-related Macular Degeneration (AMD-CNV) (left) and Polypoidal Choroidal Vasculopathy (PCV) (right).</p
Objectives: To evaluate the fundus features that can differentiate polypoidal choroidal vasculopathy...
PURPOSE: To investigate the clinical characteristics and therapeutic outcome of patients with neovas...
The first effective therapy for exudative macular degeneration (AMD) was Photodynamic Therapy (PDT)....
<p>* Treatment given before month 3 (inclusive).</p>†<p>P value to test the distribution of initial ...
<p>*P value based on Wilcoxon rank sum test.</p><p>AMD-age-related macular degeneration, PCV- polypo...
<p>P value based Wilcoxon rank sum test or Chi-square test.</p><p>AMD-age-related macular degenerati...
To study the treatment patterns and visual outcome over one year in Asian patients with choroidal ne...
Purpose. To evaluate the early response to intravitreal ranibizumab (IVR) in two different phenotype...
Age related macular degeneration (AMD) in Asians has been suggested to differ from their Western cou...
<p>* Age of presentation.</p><p>** SD, standard deviation</p><p>nAMD: neovascular age-related macula...
Polypoidal choroidal vasculopathy (PCV) is increasingly recognized as an important cause of exudativ...
Background: Polypoidal choroidal vasculopathy (PCV) is an exudative maculopathy affecting vision, wi...
PURPOSE To suggest a clinical distinction between idiopathic polypoidal choroidal vasculopathy (PCV)...
Age-related macular degeneration (AMD) is the most common cause of visual disability and blindness i...
Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent...
Objectives: To evaluate the fundus features that can differentiate polypoidal choroidal vasculopathy...
PURPOSE: To investigate the clinical characteristics and therapeutic outcome of patients with neovas...
The first effective therapy for exudative macular degeneration (AMD) was Photodynamic Therapy (PDT)....
<p>* Treatment given before month 3 (inclusive).</p>†<p>P value to test the distribution of initial ...
<p>*P value based on Wilcoxon rank sum test.</p><p>AMD-age-related macular degeneration, PCV- polypo...
<p>P value based Wilcoxon rank sum test or Chi-square test.</p><p>AMD-age-related macular degenerati...
To study the treatment patterns and visual outcome over one year in Asian patients with choroidal ne...
Purpose. To evaluate the early response to intravitreal ranibizumab (IVR) in two different phenotype...
Age related macular degeneration (AMD) in Asians has been suggested to differ from their Western cou...
<p>* Age of presentation.</p><p>** SD, standard deviation</p><p>nAMD: neovascular age-related macula...
Polypoidal choroidal vasculopathy (PCV) is increasingly recognized as an important cause of exudativ...
Background: Polypoidal choroidal vasculopathy (PCV) is an exudative maculopathy affecting vision, wi...
PURPOSE To suggest a clinical distinction between idiopathic polypoidal choroidal vasculopathy (PCV)...
Age-related macular degeneration (AMD) is the most common cause of visual disability and blindness i...
Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent...
Objectives: To evaluate the fundus features that can differentiate polypoidal choroidal vasculopathy...
PURPOSE: To investigate the clinical characteristics and therapeutic outcome of patients with neovas...
The first effective therapy for exudative macular degeneration (AMD) was Photodynamic Therapy (PDT)....